Human hydrolytic enzymes

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Incyte Corporation patent solves the following problem:

Hydrolysis is the breaking of a covalent bond to a substrate by the introduction of a water molecule. The reaction involves a nucleophilic attack of oxygen atoms in water molecules in a target substrate bond. The water molecules split across the target bond, breaking the bond and produce two molecules. Hydrolytic enzyme involved in the reactions of important functions such as cell signaling, cell proliferation, inflammation, apoptosis, secretion and excretion. Hydrolytic enzyme involved in the key steps in the disease process involving these functions. Hydrolytic enzyme, or hydrolases, a group of substrate specificity of classes including aminohydrolases, phospholipases, carboxyl-esterases, phosphodiesterases, lysozymes, glycosidases, glyoxalases, sulfatases, phosphohydrolases, and serine hydrolases.

Our analysis of this patent is as follows:

Incyte Corporation’s patent US 6872560 B1 deals with Human hydrolytic enzymes.
human invention provides hydrolytic enzymes (HYENZ) and polynucleotides which identify and encode HYENZ. the invention also provide expression vector, host cells, antibodies, agonists and antagonists. invention also provides methods for diagnosing, treating, or preventing diseases associated with expression of HYENZ.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method and system for optimizing translation buffer recovery after a miss operation within a multi-processor environment

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Hewlett-Packard Development Company, L.P. patent solves the following problem:

Distributed computer system usually consists of several computers connected to each other through a communication network. In some distributed computer systems, networked computer can simultaneously access shared data. Such systems are sometimes known as parallel computer. If a large number of networked computers, the distribution system is considered to be large like. As an advantage, the same computer to solve complex computational problems in a reasonable amount of time.

Our analysis of this patent is as follows:

Hewlett-Packard Development Company, L.P.’s patent US 6865651 B2 deals with Method and system for optimizing translation buffer recovery after a miss operation within a multi-processor environment.
A distributed computer system is disclosed that allows shared memory resources are synchronized so that proper and lasting memories shared within the computer system in the computer system distribution. The distributed computer system includes a plurality of devices, at least one memory resource shared the plurality of devices, and a memory controller, with the plurality of devices and shared memory resources. The memory controller synchronizes access to shared data stored in the memory resources of the device plural and more uniform among the plurality of devices over the announcement that an event happened simultaneously or memory resources are not shared with other devices.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Antiviral agents

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Pfizer patent solves the following problem:

The herpesviruses comprise a large family of double stranded DNA viruses. They are also a source of the most common viral disease in humans. Eight herpes virus, herpes simplex virus type 1 and 2 (HSV-1 and HSV-2), varicella zoster virus (VZV), human cytomegalovirus (HCMV), Epstein-Barr virus (EBV), and human herpes virus 6, 7, and 8 (HHV-6, HHV-7, and HHV-8), shown to infect humans.

Our analysis of this patent is as follows:

Pfizer’s patent US 6861438 B2 deals with Antiviral agents.
the invention provides a compound of formula I: where G, R2, and P3 have any of the values ​​described in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparation of such compounds or salts, and methods of treating a herpesvirus infection using such compounds or salts.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.